ArticleNeurourology and urodynamics2026
The Long-Term Effects of Sacral Neuromodulation on Urodynamic Parameters in Female Patients With Functional High-Pressure Low-Flow Voiding: A Ticking Time-Bomb?
Article in Neurourology and urodynamics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSacral neuromodulation (SNM) is used to treat women with dysfunctional voiding (DV), including those with high-pressure, low-flow (HP-LF) voiding. In this subgroup, persistent elevated voiding pressures raise concerns about long-term bladder and upper tract deterioration. Conventional urodynamic measures such as Pdet.Qmax and Qmax reflect only a single point in the voiding cycle and do not capture the full detrusor workload. The area under the pressure-flow curve (AUC) offers a more comprehensive metric of cumulative voiding pressure.
aimTo assess whether long-term SNM reduces AUC in women with HP-LF due to DV, and how this compares to changes in standard urodynamic parameters.
methodsSeven women with DV and HP-LF underwent urodynamics before and after SNM. Inclusion criteria included female patients with prolonged or irregular flow rates on urodynamics, high voiding pressures (BOOIf > 18) and either radiological evidence of dynamic mid-urethral narrowing or elevated mid-urethral closure pressure for age. Outcomes included AUC, AUC/VV (normalised to voided volume), and standard voiding/storage metrics. Symptom change was assessed via PGIC score.
resultsMedian age was 42. Median follow-up was 986 days. PGIC scores ranged 4-7 (median 6). Median (IQR) AUC decreased from 3548 (2540-6228) to 2998 (1714-4605) cmH₂O·s (p = 0.297) and AUC/VV from 20 (10-47) to 17 (3-21) cmH₂O·s·mL⁻¹ (p = 0.688). Median (IQR) Pdet.max decreased by from 54 (49-66) to 44 (40-59) cmH₂O (p = 0.047). No other pressure or flow parameters demonstrated a statistically detectable change.
conclusionLong-term SNM improves symptoms in women with HP-LF voiding but does not significantly reduce cumulative detrusor pressure. These patients may remain at risk of bladder dysfunction and warrant continued follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.